Zevra Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ZVRA Nasdaq 2830 www.zevra.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zevra Therapeutics, Inc.

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC) - Jun 23rd, 2026 5:30 am
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition - Jun 11th, 2026 6:30 am
Is Zevra Therapeutics (ZVRA) Using MIPLYFFA Patent Extensions To Deepen Its Rare-Disease Moat? - Jun 9th, 2026 3:19 pm
ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? - Jun 9th, 2026 10:50 am
ZVRA Stock ‘Way Undervalued’? Analyst Sees 117% Upside After Patent Extends Exclusivity Till 2041 For Sole Approved Drug - Jun 8th, 2026 12:19 pm
Zevra Therapeutics extends MIPLYFFA exclusivity to 2041 - Jun 8th, 2026 10:25 am
Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA - Jun 8th, 2026 5:30 am
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 29th, 2026 2:30 pm
Zevra Therapeutics' (NASDAQ:ZVRA) Earnings Aren't As Good As They Appear - May 13th, 2026 5:22 am
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference - May 12th, 2026 5:30 am
Zevra Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - May 9th, 2026 8:15 am
Is It Too Late To Consider Zevra Therapeutics (ZVRA) After The Recent Share Price Surge? - May 7th, 2026 12:19 pm
Zevra Therapeutics Q1 Earnings Call Highlights - May 7th, 2026 4:07 am
Zevra Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 6th, 2026 6:31 pm
Zevra (ZVRA) Q1 2026 Earnings Call Transcript - May 6th, 2026 4:45 pm
Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass Estimates - May 6th, 2026 4:30 pm
Zevra Reports First Quarter 2026 Financial Results and Corporate Update - May 6th, 2026 2:05 pm
Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2026 7:15 am
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call - Apr 22nd, 2026 5:30 am
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? - Mar 23rd, 2026 7:07 pm